Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, pathways, authors, ontology terms, etc. (e.g. eve, embryo, zen, allele)
  • Use OR to search for either of two terms (e.g. fly OR drosophila) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. dros* for partial matches or fly AND NOT embryo to exclude a term

Search results 3701 to 3800 out of 44733 for *

Category restricted to GOTerm (x)

<< First    < Previous  |  Next >    Last >>
0.02s

Categories

Category: GOTerm
« show all
Type Details Score
GO Term
GO:0051590 | positive regulation of neurotransmitter transport
Description: Any process that activates or increases the frequency, rate or extent of the directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0051588 | regulation of neurotransmitter transport
Description: Any process that modulates the frequency, rate or extent of the directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0036072 | direct ossification
Description: The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance, that does not require the replacement of preexisting tissues.
•
•
•
•
•
GO Term
GO:0001957 | intramembranous ossification
Description: Direct ossification that occurs within mesenchyme or an accumulation of relatively unspecialized cells.
•
•
•
•
•
GO Term
GO:0060350 | endochondral bone morphogenesis
Description: The process in which bones are generated and organized as a result of the conversion of initial cartilaginous anlage into bone.
•
•
•
•
•
GO Term
GO:0001958 | endochondral ossification
Description: Replacement ossification wherein bone tissue replaces cartilage.
•
•
•
•
•
GO Term
GO:0036075 | replacement ossification
Description: Ossification that requires the replacement of a preexisting tissue prior to bone tissue formation.
•
•
•
•
•
GO Term
GO:0060349 | bone morphogenesis
Description: The process in which bones are generated and organized.
•
•
•
•
•
GO Term
GO:0060759 | regulation of response to cytokine stimulus
Description: Any process that modulates the rate, frequency, or extent of a response to cytokine stimulus.
•
•
•
•
•
GO Term
GO:0001959 | regulation of cytokine-mediated signaling pathway
Description: Any process that modulates the frequency, rate or extent of the cytokine mediated signaling pathway.
•
•
•
•
•
GO Term
GO:0001960 | negative regulation of cytokine-mediated signaling pathway
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of the cytokine mediated signaling pathway.
•
•
•
•
•
GO Term
GO:0060761 | negative regulation of response to cytokine stimulus
Description: Any process that decreases the rate, frequency, or extent of a response to cytokine stimulus.
•
•
•
•
•
GO Term
GO:0001961 | positive regulation of cytokine-mediated signaling pathway
Description: Any process that activates or increases the frequency, rate or extent of a cytokine mediated signaling pathway.
•
•
•
•
•
GO Term
GO:0060760 | positive regulation of response to cytokine stimulus
Description: Any process that increases the rate, frequency, or extent of a response to cytokine stimulus.
•
•
•
•
•
GO Term
GO:0001962 | alpha-1,3-galactosyltransferase activity
Description: Catalysis of the transfer of a galactose residue from a donor molecule, such as GDP-galactose or UDP-galactose, to an oligosaccharide, forming an alpha-(1->3) linkage.
•
•
•
•
•
GO Term
GO:0001963 | synaptic transmission, dopaminergic
Description: The vesicular release of dopamine. from a presynapse, across a chemical synapse, the subsequent activation of dopamine receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
•
•
•
•
•
GO Term
GO:0050905 | neuromuscular process
Description: Any process pertaining to the functions of the nervous and muscular systems of an organism.
•
•
•
•
•
GO Term
GO:0001964 | startle response
Description: An action or movement due to the application of a sudden unexpected stimulus.
•
•
•
•
•
GO Term
GO:0001966 | thigmotaxis
Description: The directed movement of a motile cell or organism in response to touch.
•
•
•
•
•
GO Term
GO:0001967 | suckling behavior
Description: Specific behavior of a newborn or infant mammal that results in the derivation of nourishment from the breast.
•
•
•
•
•
GO Term
GO:0051705 | multi-organism behavior
Description: Any process in which an organism has a behavioral effect on another organism of the same or different species.
•
•
•
•
•
GO Term
GO:0001968 | fibronectin binding
Description: Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
•
•
•
•
•
GO Term
GO:0001969 | regulation of activation of membrane attack complex
Description: Any process that modulates the frequency, rate or extent of the activation of the membrane attack complex components of the complement cascade.
•
•
•
•
•
GO Term
GO:0001970 | positive regulation of activation of membrane attack complex
Description: Any process that activates, maintains or increases the frequency, rate or extent of the activation of the membrane attack complex components of the complement cascade.
•
•
•
•
•
GO Term
GO:0001971 | negative regulation of activation of membrane attack complex
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of the activation of the membrane attack complex components of the complement cascade.
•
•
•
•
•
GO Term
GO:0001972 | retinoic acid binding
Description: Interacting selectively and non-covalently with retinoic acid, 3,7-dimethyl-9-(2,6,-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid.
•
•
•
•
•
GO Term
GO:0033293 | monocarboxylic acid binding
Description: Interacting selectively and non-covalently with a monocarboxylic acid, any organic acid containing one carboxyl (COOH) group or anion (COO-).
•
•
•
•
•
GO Term
GO:0019840 | isoprenoid binding
Description: Interacting selectively and non-covalently with any isoprenoid compound, isoprene (2-methylbuta-1,3-diene) or compounds containing or derived from linked isoprene (3-methyl-2-butenylene) residues.
•
•
•
•
•
GO Term
GO:0035588 | G protein-coupled purinergic receptor signaling pathway
Description: The series of molecular signals generated as a consequence of a receptor binding to an extracellular purine or purine derivative and transmitting the signal to a heterotrimeric G-protein complex to initiate a change in cell activity.
•
•
•
•
•
GO Term
GO:0035587 | purinergic receptor signaling pathway
Description: The series of molecular signals generated as a consequence of a receptor binding to an extracellular purine or purine derivative to initiate a change in cell activity.
•
•
•
•
•
GO Term
GO:0097366 | response to bronchodilator
Description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bronchodilator stimulus. A bronchodilator is a chemical that causes an increase in the expansion of a bronchus or bronchial tubes.
•
•
•
•
•
GO Term
GO:0001975 | response to amphetamine
Description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine.
•
•
•
•
•
GO Term
GO:0014075 | response to amine
Description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amine stimulus. An amine is a compound formally derived from ammonia by replacing one, two or three hydrogen atoms by hydrocarbyl groups.
•
•
•
•
•
GO Term
GO:0001976 | nervous system process involved in regulation of systemic arterial blood pressure
Description: The regulation of blood pressure mediated by detection of stimuli and a neurological response.
•
•
•
•
•
GO Term
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure
Description: Renal process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
•
•
•
•
•
GO Term
GO:0001977 | renal system process involved in regulation of blood volume
Description: A slow mechanism of blood pressure regulation that responds to changes in pressure resulting from fluid and salt intake by modulating the quantity of blood in the circulatory system.
•
•
•
•
•
GO Term
GO:0003014 | renal system process
Description: A organ system process carried out by any of the organs or tissues of the renal system. The renal system maintains fluid balance, and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels; in other species, the renal system may comprise related structures (e.g., nephrocytes and malpighian tubules in Drosophila).
•
•
•
•
•
GO Term
GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback
Description: The process that modulates blood pressure by sensing the amount of stretch occurring in large arteries and responding to the input via central nervous system control.
•
•
•
•
•
GO Term
GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback
Description: The neural regulation of blood pressure in which baroreceptors sense the amount of stretch occurring in vessels and respond to the input via central nervous system control.
•
•
•
•
•
GO Term
GO:0001979 | regulation of systemic arterial blood pressure by chemoreceptor signaling
Description: The process that modulates blood pressure by the action of chemoreceptors found in the carotid and aortic bodies and their resultant modulation of the vasomotor center. Chemoreceptors respond to oxygen, carbon dioxide and hydrogen ions.
•
•
•
•
•
GO Term
GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions
Description: The process that modulates blood pressure by the detection of carbon dioxide levels in the brain stem. Increased levels activate the sympathetic vasoconstrictor mechanism increasing the force with which blood flows through the circulatory system.
•
•
•
•
•
GO Term
GO:0003018 | vascular process in circulatory system
Description: A circulatory process that occurs at the level of the vasculature.
•
•
•
•
•
GO Term
GO:0001981 | baroreceptor detection of arterial stretch
Description: The series of events by which the change in diameter of an artery is detected and converted to a molecular signal.
•
•
•
•
•
GO Term
GO:0009581 | detection of external stimulus
Description: The series of events in which an external stimulus is received by a cell and converted into a molecular signal.
•
•
•
•
•
GO Term
GO:0009582 | detection of abiotic stimulus
Description: The series of events in which an (non-living) abiotic stimulus is received by a cell and converted into a molecular signal.
•
•
•
•
•
GO Term
GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure
Description: The lowering of the number of nerve impulses from baroreceptors as a result of decreased stretch of an artery that results in an increased in sympathetic nerve impulses to peripheral blood vessels.
•
•
•
•
•
GO Term
GO:0003084 | positive regulation of systemic arterial blood pressure
Description: The process that increases the force with which blood travels through the systemic arterial circulatory system.
•
•
•
•
•
GO Term
GO:0045777 | positive regulation of blood pressure
Description: Any process in which the force of blood traveling through the circulatory system is increased.
•
•
•
•
•
GO Term
GO:0001983 | baroreceptor response to increased systemic arterial blood pressure
Description: The increase in nerve impulses from baroreceptors as a result of increased pressure on an artery that results in an inhibition of sympathetic nerve impulses to peripheral blood vessels.
•
•
•
•
•
GO Term
GO:0003085 | negative regulation of systemic arterial blood pressure
Description: The process that reduces the force with which blood travels through the systemic arterial circulatory system.
•
•
•
•
•
GO Term
GO:0001984 | artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure
Description: An increase in the internal diameter of an artery, triggered by vasomotor suppression, during the chemoreceptor response to decreased blood pressure.
•
•
•
•
•
GO Term
GO:0097755 | positive regulation of blood vessel diameter
Description: Any process that increases the diameter of blood vessels.
•
•
•
•
•
GO Term
GO:0035296 | regulation of tube diameter
Description: Any process that modulates the diameter of a tube.
•
•
•
•
•
GO Term
GO:0035150 | regulation of tube size
Description: Ensuring that a tube is of the correct length and diameter. Tube size must be maintained not only during tube formation, but also throughout development and in some physiological processes.
•
•
•
•
•
GO Term
GO:0010459 | negative regulation of heart rate
Description: Any process that stops, prevents or reduces the frequency or rate of heart contraction.
•
•
•
•
•
GO Term
GO:0001985 | negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of heart contraction as a result of the baroreceptor response to increased blood pressure.
•
•
•
•
•
GO Term
GO:0045822 | negative regulation of heart contraction
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of heart contraction.
•
•
•
•
•
GO Term
GO:0002027 | regulation of heart rate
Description: Any process that modulates the frequency or rate of heart contraction.
•
•
•
•
•
GO Term
GO:1903523 | negative regulation of blood circulation
Description: Any process that stops, prevents or reduces the frequency, rate or extent of blood circulation.
•
•
•
•
•
GO Term
GO:0001986 | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure
Description: Any process that decreases the force with which the cardiac muscles of the heart pump blood through the circulatory system as a result of the baroreceptor response to increased blood pressure.
•
•
•
•
•
GO Term
GO:0001987 | vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure
Description: A process that is triggered by vasomotor excitation and results in a decrease in the diameter of an artery during the baroreceptor response to decreased blood pressure.
•
•
•
•
•
GO Term
GO:0097756 | negative regulation of blood vessel diameter
Description: Any process that decreases the diameter of blood vessels.
•
•
•
•
•
GO Term
GO:0001988 | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure
Description: Any process that activates, maintains or increases the frequency, rate or extent of heart contraction as a result of the baroreceptor response to decreased blood pressure.
•
•
•
•
•
GO Term
GO:0010460 | positive regulation of heart rate
Description: Any process that activates or increases the frequency or rate of heart contraction.
•
•
•
•
•
GO Term
GO:1903524 | positive regulation of blood circulation
Description: Any process that activates or increases the frequency, rate or extent of blood circulation.
•
•
•
•
•
GO Term
GO:0001989 | positive regulation of the force of heart contraction involved in baroreceptor response to decreased systemic arterial blood pressure
Description: Any process that increases the force with which the cardiac muscles of the heart pump blood through the circulatory system as part of the baroreceptor response to decreased blood pressure.
•
•
•
•
•
GO Term
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal
Description: The regulation of blood pressure mediated by biochemical signaling: hormonal, autocrine or paracrine.
•
•
•
•
•
GO Term
GO:0001990 | regulation of systemic arterial blood pressure by hormone
Description: The process in which hormones modulate the force with which blood passes through the circulatory system. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
•
•
•
•
•
GO Term
GO:0050886 | endocrine process
Description: The process that involves the secretion of or response to endocrine hormones. An endocrine hormone is a hormone released into the circulatory system.
•
•
•
•
•
GO Term
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin
Description: The process in which angiotensinogen metabolites in the bloodstream modulate the force with which blood passes through the circulatory system. The process begins when renin is released and cleaves angiotensinogen.
•
•
•
•
•
GO Term
GO:0001992 | regulation of systemic arterial blood pressure by vasopressin
Description: The regulation of blood pressure mediated by the signaling molecule vasopressin. Vasopressin is produced in the hypothalamus, and affects vasoconstriction, and renal water transport.
•
•
•
•
•
GO Term
GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine
Description: The process in which the secretion of norepinephrine or epinephrine into the bloodstream modulates the force with which blood passes through the circulatory system.
•
•
•
•
•
GO Term
GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure
Description: A process that results in a decrease in the diameter of an artery during the norepinephrine-epinephrine response to decreased blood pressure.
•
•
•
•
•
GO Term
GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine
Description: Any process in which the force of blood traveling through the circulatory system is increased by the chemicals epinephrine and norepinephrine.
•
•
•
•
•
GO Term
GO:0001995 | norepinephrine-epinephrine catabolic process in blood stream
Description: The chemical reactions and pathways resulting in the breakdown of norepinephrine or epinephrine in the bloodstream.
•
•
•
•
•
GO Term
GO:0042419 | epinephrine catabolic process
Description: The chemical reactions and pathways resulting in the breakdown of epinephrine, a hormone produced by the medulla of the adrenal glands that increases heart activity, improves the power and prolongs the action of muscles, and increases the rate and depth of breathing. It is synthesized by the methylation of norepinephrine.
•
•
•
•
•
GO Term
GO:0042424 | catecholamine catabolic process
Description: The chemical reactions and pathways resulting in the breakdown of any of a group of physiologically important biogenic amines that possess a catechol (3,4-dihydroxyphenyl) nucleus and are derivatives of 3,4-dihydroxyphenylethylamine.
•
•
•
•
•
GO Term
GO:0019336 | phenol-containing compound catabolic process
Description: The chemical reactions and pathways resulting in the breakdown of a phenol, any compound containing one or more hydroxyl groups directly attached to an aromatic carbon ring.
•
•
•
•
•
GO Term
GO:0042414 | epinephrine metabolic process
Description: The chemical reactions and pathways involving epinephrine, a hormone produced by the medulla of the adrenal glands that increases heart activity, improves the power and prolongs the action of muscles, and increases the rate and depth of breathing. It is synthesized by the methylation of norepinephrine.
•
•
•
•
•
GO Term
GO:1901616 | organic hydroxy compound catabolic process
Description: The chemical reactions and pathways resulting in the breakdown of organic hydroxy compound.
•
•
•
•
•
GO Term
GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine
Description: The process in which the presence of epinephrine or norepinephrine in the bloodstream activates, maintains or increases the rate of heart contraction.
•
•
•
•
•
GO Term
GO:0003099 | positive regulation of the force of heart contraction by chemical signal
Description: Any process which increases the force of heart muscle contraction mediated by chemical signaling, hormonal, autocrine or paracrine.
•
•
•
•
•
GO Term
GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine
Description: Any process that increases the force with which the cardiac muscles of the heart pump blood through the circulatory system as a result of the presence of epinephrine or norepinephrine in the bloodstream or released from the nerve endings.
•
•
•
•
•
GO Term
GO:0003057 | regulation of the force of heart contraction by chemical signal
Description: The regulation of the force of heart muscle contraction mediated by chemical signaling, hormonal, autocrine or paracrine.
•
•
•
•
•
GO Term
GO:0002026 | regulation of the force of heart contraction
Description: Any process that modulates the extent of heart contraction, changing the force with which blood is propelled.
•
•
•
•
•
GO Term
GO:0002034 | regulation of blood vessel diameter by renin-angiotensin
Description: The process in which the diameter of a blood vessel is changed due to activity of the renin-angiotensin system.
•
•
•
•
•
GO Term
GO:0001998 | angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure
Description: The decrease in blood vessel diameter as a result of the release of angiotensin into the blood stream.
•
•
•
•
•
GO Term
GO:0003072 | renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
Description: The renal process that modulates the force with which blood travels through the circulatory system, by impeding blood flow through the peripheral vasculature.
•
•
•
•
•
GO Term
GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure
Description: The physiological response of the kidneys to a decrease in blood flow.
•
•
•
•
•
GO Term
GO:0002000 | detection of renal blood flow
Description: The process in which the juxtaglomerular cells of the kidneys receive information about the amount of blood flowing through the arterioles and converts the information to a molecular signal.
•
•
•
•
•
GO Term
GO:0002001 | renin secretion into blood stream
Description: The regulated release of renin into the blood stream by juxtoglomerular cells.
•
•
•
•
•
GO Term
GO:0002002 | regulation of angiotensin levels in blood
Description: The process that modulates the level of any of the various angiotensinogen proteolytic products in the blood. This occurs by the proteolytic cleavage of angiotensinogen, and its proteolytic products, to create a variety of active peptide hormones, such as angiotensin I and angiotensin II, as well as through the removal of these peptides from the circulation.
•
•
•
•
•
GO Term
GO:0002003 | angiotensin maturation
Description: The process leading to the attainment of the full functional capacity of angiotensin by conversion of angiotensinogen into mature angiotensin in the blood.
•
•
•
•
•
GO Term
GO:0002004 | secretion of vasopressin involved in fast regulation of systemic arterial blood pressure
Description: The regulated release of the hormone vasopressin into the blood stream by the hypothalamus and pituitary gland contributing to fast regulation of blood pressure.
•
•
•
•
•
GO Term
GO:0030103 | vasopressin secretion
Description: The regulated release of vasopressin from secretory granules into the blood.
•
•
•
•
•
GO Term
GO:0002006 | vasoconstriction by vasopressin involved in systemic arterial blood pressure control
Description: The decrease in blood vessel diameter as a result of the release of vasopressin into the blood stream.
•
•
•
•
•
GO Term
GO:0002007 | detection of hypoxic conditions in blood by chemoreceptor signaling
Description: The process in which information about a lack of oxygen are received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
•
•
•
•
•
GO Term
GO:0002008 | excitation of vasomotor center by chemoreceptor signaling
Description: The process in which the molecular signal from the carotid and aortic bodies is relayed to the vasomotor center, causing it to signal an increase arterial pressure.
•
•
•
•
•
GO Term
GO:0002010 | excitation of vasomotor center by baroreceptor signaling
Description: The process in which the molecular signal from the arterial baroreceptors is relayed to the vasomotor center causing it to signal increase arterial pressure.
•
•
•
•
•
GO Term
GO:0002011 | morphogenesis of an epithelial sheet
Description: The process in which the anatomical structures of an epithelial sheet are generated and organized. An epithelial sheet is a flat surface consisting of closely packed epithelial cells.
•
•
•
•
•
USDA
InterMine logo
The Legume Information System (LIS) is a research project of the USDA-ARS:Corn Insects and Crop Genetics Research in Ames, IA.
LegumeMine || ArachisMine | CicerMine | GlycineMine | LensMine | LupinusMine | PhaseolusMine | VignaMine | MedicagoMine
InterMine © 2002 - 2022 Department of Genetics, University of Cambridge, Downing Street, Cambridge CB2 3EH, United Kingdom